Collaborative Influenza Vaccine Innovation Centers (CIVICs): Component B: Vaccine Manufacturing and Toxicology Core
$529,176N01FY2025AINIH
Duke University, Durham NC
Investigators
Abstract
To provide expertise and state-of-the-art approaches to manufacture, formulate, optimize, and evaluate the safety and toxicity of innovative, cutting-edge influenza vaccine platforms and approaches.
View original record on NIH RePORTER →